Clinical Trial Update: Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers [Phase 1]

View source ↗

Summary

This document reports a Phase I study evaluating LBH589 (panobinostat) in combination with erlotinib for advanced aerodigestive tract cancers, including lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• LBH589 (panobinostat)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung Cancer, Head and Neck Cancer | Phase 1 | Status: COMPLETED